Body weight, gender and response to TNF-α blockers in axial spondyloarthritis. [electronic resource]
Producer: 20140617Description: 875-81 p. digitalISSN:- 1462-0332
- Adalimumab
- Adult
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antirheumatic Agents -- therapeutic use
- Axis, Cervical Vertebra
- Body Mass Index
- Body Weight -- physiology
- Etanercept
- Female
- Follow-Up Studies
- Humans
- Immunoglobulin G -- therapeutic use
- Infliximab
- Logistic Models
- Male
- Middle Aged
- Obesity -- complications
- Overweight -- complications
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Retrospective Studies
- Sex Factors
- Spondylarthritis -- drug therapy
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.